Most cited papers from Ilya Pharma (Sweden)

Ilya Pharma (Sweden)

What are the most cited papers from Ilya Pharma (Sweden)?

The most cited paper from Ilya Pharma (Sweden) is "Shaping the Tumor Stroma and Sparking Immune Activation by CD40 and 4-1BB Signaling Induced by an Armed Oncolytic Virus" (Emma Eriksson, Ioanna E. Milenova, Jessica Wenthe et al., 2017), with 156 citations. Next come "The discovery and development of topical medicines for wound healing" (113) and "Engineered bacteria to accelerate wound healing: an adaptive, randomised, double-blind, placebo-controlled, first-in-human phase 1 trial" (46).

Published TypeFieldAccess

Showing 13 of 13 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Shaping the Tumor Stroma and Sparking Immune Activation by CD40 and 4-1BB Signaling Induced by an Armed Oncolytic Virus Emma Eriksson, Ioanna E. Milenova, Jessica Wenthe et al. · Clinical Cancer Research	23 May 2017	156
2	The discovery and development of topical medicines for wound healing Emelie Öhnstedt, Hava Lofton Tomenius, Evelina Vågesjö et al. · Expert Opinion on Drug Discovery Open access	14 Mar 2019	113
3	Engineered bacteria to accelerate wound healing: an adaptive, randomised, double-blind, placebo-controlled, first-in-human phase 1 trial Emelie Öhnstedt, Evelina Vågesjö, Andreas E. R. Fasth et al. · EClinicalMedicine Open access	25 May 2023	46
4	A phase 2a clinical study on the safety and efficacy of individualized dosed mebendazole in patients with advanced gastrointestinal cancer Sharmineh Mansoori, Mårten Fryknäs, Carina Alvfors et al. · Scientific Reports Open access	26 Apr 2021	33
5	Accelerated Wound Healing in Minipigs by On-Site Production and Delivery of CXCL12 by Transformed Lactic Acid Bacteria Emelie Öhnstedt, Hava Lofton Tomenius, Peter Frank et al. · Pharmaceutics Open access	19 Jan 2022	26
6	Single-Cell RNA Analysis Reveals Cell-Intrinsic Functions of CAR T Cells Correlating with Response in a Phase II Study of Lymphoma Patients Tina Sarén, Mohanraj Ramachandran, Gustav Gammelgård et al. · Clinical Cancer Research Open access	4 Aug 2023	18
7	The Impact of Formulation and Freeze Drying on the Properties and Performance of Freeze-Dried Limosilactobacillus reuteri R2LC Nisha Tyagi, Zandra Gidlöf, Daniel Tristan Osanlóo et al. · Applied Microbiology Open access	3 Dec 2023	15
8	Evaluation of Diffusion-Weighted MRI and FDG-PET/CT to Assess Response to AdCD40L treatment in Metastatic Melanoma Patients Aglaia Schiza, Sandra Irenaeus, Francisco Ortiz‐Nieto et al. · Scientific Reports Open access	2 Dec 2019	12
9	CD40 stimulation via CD40 ligand enhances adenovirus‐mediated tumour immunogenicity including ‘find‐me’, ‘eat‐me’, and ‘kill‐me’ signalling Sedigheh Naseri, Mariela Mejia Cordova, Jessica Wenthe et al. · Journal of Cellular and Molecular Medicine Open access	17 Mar 2024	8
10	Oral administration of CXCL12-expressing Limosilactobacillus reuteri improves colitis by local immunomodulatory actions in preclinical models Emelie Öhnstedt, Cristian Doñas, Kristel Parv et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology Open access	23 May 2024	5
11	Tumor Microenvironment Gene Engineering with LOAd703 in Patients with Solid Malignancies: LOKON002 Phase I/IIb Clinical Trial Amanda Hahn, Sandra Irenaeus, Linda C. Sandin et al. · Clinical Cancer Research	29 Apr 2026	1
12	Reverting Colitis Symptoms by Oral Administration of L. reuteri Expressing CXCL12 Acting Through Novel Pathway Demonstrated in Two Experimental Animal Models Emelie Öhnstedt, Cristian Doñas Cuadra, Hava Lofton Tomenius et al. · The FASEB Journal	May 2022	1
13	Elimination of highly multidrug-resistant wound bacteria by the lactic acid bacterial drug candidate ILP100 Hava Lofton Tomenius, Yanhong Pang, Anton Pallin et al. · Research Square PreprintOpen access	19 Dec 2024	0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.